文献速递临床试验与 GCP

远端胰腺切除术后预防性腹腔引流与不留置引流(PANDORINA):一项两国多中心随机对照试验

Prophylactic abdominal drainage or no drainage after distal pancreatectomy (PANDORINA): a binational multicenter randomized controlled trial.
PubMed 文献 · Trials · 2022-09-24

PANDORINA试验为两国多中心随机对照非劣效性试验,将141例择期远端胰腺切除患者随机分为引流组与无引流组,评估不留置预防性腹腔引流对术后严重并发症(Clavien-Dindo评分≥3)的非劣效性,次要结局包括B/C级术后胰瘘等。

要点

  • 远端胰腺切除术后预防性腹腔引流是当前标准做法,但其必要性受到质疑。
  • 该试验按D-FRS分层为高、低危术后胰瘘组,采用标准化胰腺残端闭合技术。
  • 主要结局为Clavien-Dindo评分≥3的术后并发症发生率,非劣效设计。

核心结论

  • PANDORINA试验旨在验证远端胰腺切除术后不留置预防性腹腔引流不增加术后严重并发症风险的假设,为两国多中心随机对照非劣效性试验。

研究设计与样本

  • 两国多中心随机对照非劣效性试验,将患者按B/C级术后胰瘘高风险和低风险分层,并采用标准化胰腺横断技术。
  • 计划纳入282例择期远端胰腺切除患者,引流组与无引流组各141例,手术方式为开腹或微创,伴或不伴脾切除。

主要发现

  • 主要结局为Clavien-Dindo评分≥3的术后并发症发生率,最相关的次要结局为B/C级术后胰瘘。
  • 其他次要结局包括手术再干预、经皮导管引流、内镜下导管引流、腹腔积液(无需引流)、伤口感染、胃排空延迟、国际胰腺外科研究组(ISGPS)定义的胰切除术后出血、住院时间、90天内再入院、院内死亡及90天死亡。

局限性

  • 此前一项多中心随机对照试验虽证实了省略腹腔引流的安​​全性,但未按术后胰瘘风险对患者进行分层,也未描述标准化的胰腺横断策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prophylactic abdominal drainage is current standard practice after distal pancreatectomy (DP), with the aim to divert pancreatic fluid in case of a postoperative pancreatic fistula (POPF) aimed to prevent further complications as bleeding. Whereas POPF after pancreatoduodenectomy, by definition, involves infection due to anastomotic dehiscence, a POPF after DP is essentially sterile since the bowel is not opened and no anastomoses are created. Routine drainage after DP could potentially be omitted and this could even be beneficial because of the hypothetical prevention of drain-induced infections (Fisher, Surgery 52:205-22, 2018). Abdominal drainage, moreover, should only be performed if it provides additional safety or comfort to the patient. In clinical practice, drains cause clear discomfort. One multicenter randomized controlled trial confirmed the safety of omitting abdominal drainage but did not stratify patients according to their risk of POPF and did not describe a standardized strategy for pancreatic transection. Therefore, a large pragmatic multicenter randomized controlled trial is required, with prespecified POPF risk groups and a homogeneous method of stump closure. The objective of the PANDORINA trial is to evaluate the non-inferiority of omitting routine intra-abdominal drainage after DP on postoperative morbidity (Clavien-Dindo score ≥ 3), and, secondarily, POPF grade B/C. METHODS/DESIGN: Binational multicenter randomized controlled non-inferiority trial, stratifying patients to high and low risk for POPF grade B/C and incorporating a standardized strategy for pancreatic transection. Two groups of 141 patients (282 in total) undergoing elective DP (either open or minimally invasive, with or without splenectomy). Primary outcome is postoperative rate of morbidity (Clavien-Dindo score ≥ 3), and the most relevant secondary outcome is grade B/C POPF. Other secondary outcomes include surgical reintervention, percutaneous catheter drainage, endoscopic catheter drainage, abdominal collections (not requiring drainage), wound infection, delayed gastric emptying, postpancreatectomy hemorrhage as defined by the international study group for pancreatic surgery (ISGPS) (Wente et al., Surgery 142:20-5, 2007), length of stay (LOS), readmission within 90 days, in-hospital mortality, and 90-day mortality. DISCUSSION: PANDORINA is the first binational, multicenter, randomized controlled non-inferiority trial with the primary objective to evaluate the hypothesis that omitting prophylactic abdominal drainage after DP does not worsen the risk of postoperative severe complications (Wente etal., Surgery 142:20-5, 2007; Bassi et al., Surgery 161:584-91, 2017). Most of the published studies on drain placement after pancreatectomy focus on both pancreatoduodenectomy and DP, but these two entities present are associated with different complications and therefore deserve separate evaluation (McMillan et al., Surgery 159:1013-22, 2016; Pratt et al., J Gastrointest Surg 10:1264-78, 2006). The PANDORINA trial is innovative since it takes the preoperative risk on POPF into account based on the D-FRS and it warrants homogenous stump closing by using the same graded compression technique and same stapling device (de Pastena et al., Ann Surg 2022; Asbun and Stauffer, Surg Endosc 25:2643-9, 2011).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Vissers FL, Balduzzi A, van Bodegraven EA, et al. Prophylactic abdominal drainage or no drainage after distal pancreatectomy (PANDORINA): a binational multicenter randomized controlled trial. Trials. 2022. PMID: 36153559. doi:10.1186/s13063-022-06736-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。